Altered levels of the soluble IL-1, IL-4 and TNF receptors, as well as the IL-1 receptor antagonist, in intermittent allergic rhinitis

被引:16
|
作者
Benson, M [1 ]
Wennergren, G
Fransson, M
Cardell, LO
机构
[1] Queen Silvia Childrens Hosp, Pediat Allergy Res Grp, SE-41685 Gothenburg, Sweden
[2] Lund Univ, Malmo Univ Hosp, Dept Otorhinolaryngol, Lab Clin & Expt Allergol, Malmo, Sweden
关键词
cytokines; soluble; interleukins; receptors; rhinitis;
D O I
10.1159/000078770
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: The effects of cytokines are modulated by soluble cytokine receptors (SCR) and receptor antagonists. Therefore, allergic disease may depend on altered proportions between cytokines, their SCR and receptor antagonists, rather than absolute changes in cytokine levels. Little is known about SCR in intermittent allergic rhinitis (IAR). Objective: To examine the concentrations of SCR, i.e. sIL-1R2, sIL-4R, sIL-6R and sTNFR1, as well as the interleukin-1 receptor antagonist (IL-1Ra) in nasal fluids from allergen-challenged patients with IAR and healthy controls. Methods: 30 patients with birch- or grass-pollen-induced IAR and 30 healthy controls were studied. In the patients nasal fluids were obtained before as well as 1 and 6 h after allergen provocation. Results: Both symptom scores and rhinoscopic signs of rhinitis increased in the patients after allergen challenge. Comparisons between patients and controls showed that sIL-4R was lower in patients before and 1 and 6 h after provocation. IL-1Ra was lower before and 1 h after provocation. In addition, lower concentrations of sTNFR1 were found in patients after 1 h, while sIL-1R2 concentrations were higher after 1 h. Comparisons of patients before and after challenge showed that IL-1Ra and sTNFR1 decreased after 1 h, while sIL-1R2 increased. No significant differences were found compared to 6 h. sIL-6R did not significantly differ between the study groups. Conclusions: After allergen challenge, significant changes in the nasal fluid levels of IL-1Ra, sIL-1R2 and sTNFR1 were found. By contrast, sIL-4R remained at lower levels than in controls both before and after challenge. Since sIL-4R modulates IgE synthesis, this may play a role in the pathogenesis of IAR. Copyright (C) 2004 S. Karger AG, Basel.
引用
收藏
页码:227 / 232
页数:6
相关论文
共 50 条
  • [31] A tissue specific IL-1 receptor antagonist homolog front the IL-1 cluster lacks IL-1, IL-1ra, IL-18 and IL-18 antagonist activities
    Barton, JL
    Herbst, R
    Bosisio, D
    Higgins, L
    Nicklin, MJH
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2000, 30 (11) : 3299 - 3308
  • [32] Regulation of IL-1 by IL-1 decoy receptor
    Cheryl Smythe
    Arthritis Research & Therapy, 3 (1)
  • [33] Altered ryanodine receptor gating by TNF-α and IL-1β
    Duncan, David
    Yang, Zhaokang
    Hopkins, Philip M.
    Steele, Derek S.
    Harrison, Simon M.
    BIOPHYSICAL JOURNAL, 2007, : 88A - 88A
  • [34] The cytokines IL-1β and IL-1 receptor antagonist, IL-2 and IL-2 soluble receptor-α, IL-6 and IL-6 soluble receptor, TNF-α and TNF soluble receptor I, and IL10 in drained and systemic blood after major orthopaedic surgery
    Krohn, CD
    Reikerås, O
    Aasen, AO
    EUROPEAN JOURNAL OF SURGERY, 1999, 165 (02) : 101 - 109
  • [35] MODULATION OF THE IL-1 CYTOKINE NETWORK IN KERATINOCYTES BY INTRACELLULAR IL-1-ALPHA AND IL-1 RECEPTOR ANTAGONIST
    PHILLIPS, WG
    FELDMANN, M
    BREATHNACH, SM
    BRENNAN, FM
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1995, 101 (01): : 177 - 182
  • [36] THE SYNTHESIS OF IL-1 RECEPTOR ANTAGONIST (IL-1RA) BY SYNOVIAL FIBROBLASTS IS MARKEDLY INCREASED BY THE CYTOKINES TNF-ALPHA AND IL-1
    MARTELPELLETIER, J
    MCCOLLUM, R
    PELLETIER, JP
    BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1175 (03) : 302 - 305
  • [37] THE BALANCE BETWEEN IL-1 AND IL-1 RECEPTOR ANTAGONIST (IL-1RA) IN CROHNS-DISEASE
    DUCHINI, A
    TONELLI, F
    COMINELLI, F
    CLINICAL RESEARCH, 1992, 40 (02): : A356 - A356
  • [38] Interleukin (IL)-1β, IL-1α, and IL-1 receptor antagonist gene polymorphisms in patients with temporal lobe epilepsy
    Kanemoto, K
    Kawasaki, J
    Miyamoto, T
    Obayashi, H
    Nishimura, M
    ANNALS OF NEUROLOGY, 2000, 47 (05) : 571 - 574
  • [39] Regulatory effects of interleukin (IL)-1, interferon-β, and IL-4 on the production of IL-1 receptor antagonist by human adipose tissue
    Juge-Aubry, CE
    Somm, E
    Chicheportiche, R
    Burger, D
    Pernin, A
    Cuénod-Pittet, B
    Quinodoz, P
    Guisti, V
    Dayer, JM
    Meier, CA
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (06): : 2652 - 2658
  • [40] Immunohistochemical staining of IL-1α, IL-1β and IL-1 receptor antagonist in murine co-cultures of Sertoli/germ cells
    Lunenfeld, E
    Huleihel, M
    Zeyse, D
    Beck, M
    Prinsloo, I
    Potashnik, G
    Mazor, M
    HUMAN REPRODUCTION, 2000, 15 : 85 - 85